and your Mirion the hard Larry, morning all continued thank get to To everyone. work determination to you good my colleagues thank I things started, want say quarter. you and during to for of
of that commendable. And of key There like the challenges are the role focus results last be Your played proud few delivering morning. of few you've the faced has should business second areas dedication overcoming is our a I'd in this and quarter. tenacity highlight quarters we to over all the in the out reported you coming
in from with order both notching the outstanding a first delivered last the increases. Industrial year increase period XX% growth same half, Medical strong contributing we First, and
Second, supply order quarter, in segment chain segment Industrial by dynamics unfavorable impact challenges. supply those meaningful concentrated in was and chain that the noted encouraged overall. to Medical's on We this immune performance had the quarter not timing the a were noting
Even high achieve our our degree Third, exchange, headwinds we and confident gives half in supply our us order support for expectations. our are a of guidance. inflation, second in with reaffirmed to foreign ability XXXX strong chain momentum
want Before encouraged, we and are heading performance, in on half. second into are our seeing we into what financial markets time we the why I get to some spend end
US, slide Beginning you'll are in see the in especially our robust supported to year-to-date strong Turning therapy the order the seen bolstered healthcare end capital in our discussed Medical, dosimetry. order markets. intake. performance with across in radiation occupational is clear moderated, consistently while stronger have COVID-related trends positive momentum, budgets growth businesses, our nuclear advantage has medicine organic It four, and growth as and system have Clinic performance manifesting technology we've impacts we've
Regarding industrial sentiment remains and nuclear optimistic. our power,
focus gas fleet. prices, seen managing capacity shifts Germany. Moreover, we regarding We our on deteriorating which to global of Korea, fence one power, the changed potentially improved This marginal Japan, of of future tandem in that power has Belgium, nuclear been the places the like pronuclear nuclear Sweden, and upgrades. the of seen have the life South from have fundamentally Switzerland, have operators elevated in even economics countries popular extensions government and and of all support strong economics with in have natural
within faced nuclear active, energy alternative energy global energy way become European all a supply EU new has the acute for far taxonomy, increases paving instability in recently more the economic planning price Union. incentives in for and markets. source within the as build power the green Moreover, a major given as New environmental additional their green nuclear classified
continued wins relationships end markets differentiated Order portfolio diversified matrix. demand defense product in market great also with long-standing supported digital up supporting Our in are are categories. defensible incumbent the by European quarter. commitments for shift been militaries continued key reflecting these the and ramping programs, funding progress, to and the industrial and and our experienced in have threat position, launches growth has offerings. Mirion's product new leadership dynamic
on As portfolio and a are connected company, we offering digitizing products. focused and our smarter more
encouraged see to around continue are with recent within technology engagement platform. occupational and We elevated our Instadose engagement dosimetry the by
a II full-featured want is quarter launch to example congratulate the I world's the Lynx offered. to analyzer, signal yet the another innovative is innovative analyzer teams our Additionally, ever bringing team's our this during is of II of capabilities. digital which Lynx advanced multichannel on market. most product prime the
more pipeline Our This unmanned is safely the to excited technology for the late August upcoming moon. ensuring on we're or I innovations and test future. the to robust I'm the the with forward also to our look mission and play new announce spacecraft moon product spacecraft sharing in CIRS to involved. mission carry Orion for and that astronauts can Mirion early September, the of development is Phantom remains providing Artemis thrilled set be that purpose to
in the quarter, before Hanhikivi impact I agreements We've any to I committed commercial want additional on results to cancellations previously Lastly, updated not business. you Finland the sanctions other our for than conflict cancellation seen placed project of the or reported. on turn the Russia-Ukraine on keep
strong to stand and outstanding customers with we relationships Our ready commitments. remain satisfy
Turning our now second to company-wide slide quarter five results. to discuss
communication order While key buffer, responded inventory the continuing the a supply We've side, we continued challenges experienced quarter. Medical and build in defensive with on key saw during supply tightening by product positive momentum we partners timing chain are chain book and ship categories. with and Industrial to
within for of the organic X.X% the to the addition, same XXXX, results Getting year, the nearly very compared have by with lost for order pricing and morning. Russian-related call, we the our but meaningful In Medical quarter, reported later as by in to in growing we initiatives evidenced balance revenue Industrial XX.X% provided into by declined worked compensate details, support X%. the strong X.X% inflow not give contribution topline. more revenue, this but in backlog, the and declining period hard only delivering the quarter, will to color to a by you Brian the
cost initiatives. positive second from incremental throughout We benefits strategic contributor half, with the price relationship a cost expect to be net our along our
Lastly, X to that, of growth to we points XX note on our want remain target growth top I inorganic committed each line to of executing year.
achieving Our clear, leverage a to opportunities To EBITDA. demonstrated times ability acquisition is while goal path we targets, integrate simultaneously reducing have accretive our core to of and our working medium-term DNA. source of I'm our adjusted to confident towards three be
continued to Brian, Before things our want I over thank to support. hand investors for their I
this of Financial of Brian Brian? With gives positive call will of order future Our pass confidence trends second the the to continuation I Officer, and momentum in our me the half Chief end our and over growth in business. that, the Schopfer. market year,